[go: up one dir, main page]

SE8305328L - Isolering av icke nedbruten rna - Google Patents

Isolering av icke nedbruten rna

Info

Publication number
SE8305328L
SE8305328L SE8305328A SE8305328A SE8305328L SE 8305328 L SE8305328 L SE 8305328L SE 8305328 A SE8305328 A SE 8305328A SE 8305328 A SE8305328 A SE 8305328A SE 8305328 L SE8305328 L SE 8305328L
Authority
SE
Sweden
Prior art keywords
dna
sub
sequence
microorganisms
rna
Prior art date
Application number
SE8305328A
Other languages
English (en)
Other versions
SE8305328D0 (sv
Inventor
W J Rutter
H M Goodman
A Ullrich
J Shine
J M Chirgwin
R L Pictet
P H Seeburg
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05897710 external-priority patent/US4363877B1/en
Priority claimed from US05/898,887 external-priority patent/US4264731A/en
Application filed by Univ California filed Critical Univ California
Publication of SE8305328L publication Critical patent/SE8305328L/sv
Publication of SE8305328D0 publication Critical patent/SE8305328D0/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57518—Placental lactogen; Chorionic somatomammotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Claims (1)

1. Patentkrav FOrfarande for framstallning av ett cellextrakt, som ar i huvudsak fritt Ern RNas-aktivitet,kannetecknat av att on cellpopulation homogeniseras vid reglerat pH i nArvaro av ett proteindenatureringsmedel och ett disulfidbindningar uppbrytande medal i combination med varandra.
SE8305328A 1977-05-27 1983-09-29 Isolering av icke nedbruten rna SE8305328D0 (sv)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US80134377A 1977-05-27 1977-05-27
US80502377A 1977-06-09 1977-06-09
US89770978A 1978-04-19 1978-04-19
US05897710 US4363877B1 (en) 1977-09-23 1978-04-19 Recombinant dna transfer vectors
US05/898,887 US4264731A (en) 1977-05-27 1978-04-21 DNA Joining method
US89900278A 1978-04-26 1978-04-26
US89900378A 1978-04-26 1978-04-26

Publications (2)

Publication Number Publication Date
SE8305328L true SE8305328L (sv) 1983-09-29
SE8305328D0 SE8305328D0 (sv) 1983-09-29

Family

ID=27569921

Family Applications (4)

Application Number Title Priority Date Filing Date
SE7806086A SE451461B (sv) 1977-05-27 1978-05-26 Plasmid med nukleotidsekvens innehallande en sekvens som kodar for a- eller b-kedjan i insulin och forfarande for dess framstellning samt e.coli innehallande plasmiden och forfarande for framstellning av e.coli
SE8305327A SE8305327L (sv) 1977-05-27 1983-09-29 Isolering av differentierade celler
SE8305329A SE455794B (sv) 1977-05-27 1983-09-29 Plasmid med nukleotidsekvens som kodar for aminosyrasekvensen i humant tillvexthormon och forfarande for framstellning derav
SE8305328A SE8305328D0 (sv) 1977-05-27 1983-09-29 Isolering av icke nedbruten rna

Family Applications Before (3)

Application Number Title Priority Date Filing Date
SE7806086A SE451461B (sv) 1977-05-27 1978-05-26 Plasmid med nukleotidsekvens innehallande en sekvens som kodar for a- eller b-kedjan i insulin och forfarande for dess framstellning samt e.coli innehallande plasmiden och forfarande for framstellning av e.coli
SE8305327A SE8305327L (sv) 1977-05-27 1983-09-29 Isolering av differentierade celler
SE8305329A SE455794B (sv) 1977-05-27 1983-09-29 Plasmid med nukleotidsekvens som kodar for aminosyrasekvensen i humant tillvexthormon och forfarande for framstellning derav

Country Status (21)

Country Link
JP (1) JPH0659218B2 (sv)
AR (1) AR225404A1 (sv)
AU (1) AU521903B2 (sv)
BE (1) BE867424A (sv)
BG (1) BG40319A3 (sv)
CH (1) CH642680A5 (sv)
DD (1) DD145927A5 (sv)
DE (2) DE2858357C2 (sv)
DK (2) DK233278A (sv)
FI (1) FI64640C (sv)
FR (1) FR2392033B1 (sv)
GB (1) GB1565190A (sv)
GR (1) GR73552B (sv)
IL (1) IL54790A (sv)
IT (1) IT1094934B (sv)
LU (1) LU79714A1 (sv)
NL (1) NL7805591A (sv)
NZ (1) NZ187300A (sv)
PL (1) PL140200B1 (sv)
PT (1) PT68082B (sv)
SE (4) SE451461B (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA782933B (en) * 1977-09-23 1979-05-30 Univ California Purification of nucleotide sequences suitable for expression in bacteria
BR7807290A (pt) * 1977-11-08 1979-06-12 Genentech Inc Plasmideo,processo para producao de um polipeptido especifico veiculo clonal,cultura bacteriana transformante,processo para produzir uma substancia imunogenica processo para preparar um gene estrutural,e polidesoxirribonucleotido de faixa dupla
GR71912B (sv) * 1978-08-11 1983-08-16 Univ California
US6270955B1 (en) 1978-12-22 2001-08-07 Biogen, Inc. Pharmaceutical compositions and methods for producing antibodies to hepatitis b virus and kits and methods for detecting antibodies to hepatitis b virus
JPS55150883A (en) * 1979-05-11 1980-11-25 Nakano Vinegar Co Ltd Method of storing "mozuku"
ZA802992B (en) * 1979-06-01 1981-10-28 Univ California Human pre-growth hormone
FR2458584A1 (fr) * 1979-06-08 1981-01-02 Pasteur Institut Vecteurs pour le transfert et l'expression de materiel genetique dans une cellule eucaryote et procede pour la production d'une proteine determinee dans des cellules eucaryotes
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
GR70279B (sv) * 1979-09-12 1982-09-03 Univ California
IL58765A (en) * 1979-11-21 1986-09-30 Yeda Res & Dev Process for the production of essentially pure messenger rna of human fibroblast interferon and process for the production of interferon beta
DE3001928A1 (de) * 1980-01-19 1981-08-06 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
IL61982A (en) * 1980-02-15 1984-01-31 Cpc International Inc Genetically engineered microorganisms for massive production of amyloytic enzymes and process for preparing same using the corresponding recombinant dnas containing amylase coding genes
US4350764A (en) * 1980-03-10 1982-09-21 The Regents Of The University Of California Microbiological synthesis of beta endorphin
CA1202581A (en) * 1980-03-27 1986-04-01 Saran A. Narang Adaptor molecules for dna and their application to synthesis of gene-derived products
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
EP0054331B1 (en) * 1980-12-12 1992-06-03 Unilever N.V. Structural genes encoding the various allelic and maturation forms of preprothaumatin and mutations thereof, recombinant cloning vehicles comprising said structural genes and expression thereof in transformed microbial host cells
ATE22327T1 (de) * 1980-12-12 1986-10-15 Unilever Nv Dna-sequenzen fuer verschiedene allele formen des reifen thaumatins, diese sequenzen enthaltende rekombinante plasmide, verfahren zur herstellung dieser plasmide, diese rekombinante plasmide enthaltende bakterielle kulturen und verfahren zur herstellung von reifen thaumatin.
US4748233A (en) * 1982-03-23 1988-05-31 Bristol-Myers Company Alpha-interferon Gx-1
US4695543A (en) * 1982-03-23 1987-09-22 Bristol-Myers Company Alpha Interferon GX-1
EP0103395A3 (en) * 1982-08-17 1985-05-22 Biogen N.V. Dna sequences, recombinant dna molecules and processes for producing bovine growth hormone-like polypeptides in high yield
US5474980A (en) * 1984-10-04 1995-12-12 Monsanto Company Prolonged release of biologically active somatotropins
US5411951A (en) * 1984-10-04 1995-05-02 Monsanto Company Prolonged release of biologically active somatotropin
DK257988D0 (da) * 1988-05-11 1988-05-11 Novo Industri As Nye peptider
DE4034702A1 (de) * 1990-10-31 1992-05-07 Siemens Ag Verfahren und vorrichtung zur pruefung der aktiven werkzeuge von gesenkbiegemaschinen, insbesondere von biegestempeln

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1521032A (en) * 1974-08-08 1978-08-09 Ici Ltd Biological treatment

Also Published As

Publication number Publication date
SE8305327D0 (sv) 1983-09-29
BE867424A (fr) 1978-09-18
FI781675A (fi) 1978-11-28
PT68082A (en) 1978-06-01
IL54790A (en) 1983-07-31
DK233278A (da) 1978-11-28
DK791D0 (da) 1991-01-04
JPS5449387A (en) 1979-04-18
FR2392033A1 (fr) 1978-12-22
SE8305329L (sv) 1983-09-29
BG40319A3 (en) 1986-11-14
AU521903B2 (en) 1982-05-06
GR73552B (sv) 1984-03-14
IT1094934B (it) 1985-08-10
DE2858357C2 (sv) 1990-03-15
PL207176A1 (pl) 1979-03-26
FI64640B (fi) 1983-08-31
DE2822568C2 (sv) 1989-08-31
PT68082B (en) 1980-02-20
FI64640C (fi) 1983-12-12
DD145927A5 (de) 1981-01-14
NZ187300A (en) 1982-08-17
SE8305327L (sv) 1983-09-29
SE455794B (sv) 1988-08-08
DE2822568A1 (de) 1978-12-14
IT7823930A0 (it) 1978-05-29
IL54790A0 (en) 1978-07-31
SE8305329D0 (sv) 1983-09-29
SE7806086L (sv) 1978-11-28
AU3648878A (en) 1979-11-29
GB1565190A (en) 1980-04-16
DK791A (da) 1991-01-04
FR2392033B1 (fr) 1985-09-13
SE451461B (sv) 1987-10-12
LU79714A1 (fr) 1978-11-06
SE8305328D0 (sv) 1983-09-29
NL7805591A (nl) 1978-11-29
AR225404A1 (es) 1982-03-31
JPH0659218B2 (ja) 1994-08-10
PL140200B1 (en) 1987-04-30
CH642680A5 (en) 1984-04-30

Similar Documents

Publication Publication Date Title
SE8305328L (sv) Isolering av icke nedbruten rna
US4440859A (en) Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
YU55100A (sh) Postupak za fermentacionu proizvodnju d-pantotenske kiseline upotrebom bakterija korinskog oblika
WO2003008604A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated aceb gene
Beaudry et al. An efficient strategy for the synthesis of circular RNA molecules
WO2003008610A3 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced pfkb gene
DE69430993D1 (de) Kontrollierte expression transgener konstrukte in pflanzenplastiden
CN112852846A (zh) 青虾Cathepsin L基因、其dsRNA及应用
WO2001019966A3 (en) Isolation of muscle-derived stem cells and uses therefor
Dube et al. A structural requirement for codon-anticodon interaction on the ribosome
CN114480326B (zh) 亚精胺衍生物糖基转移酶LbUGT73及其编码基因和应用
WO2002098455A8 (en) Production of recombinant human arylsulfatase a
Sparmann et al. Tissue homogenization as a key step in extracting RNA from human and rat pancreatic tissue
WO2005071094A3 (en) Method for producing l-threonine using recombinant enterobacteriaceae with incre ased enolase activity
BR0005798A (pt) Processo para preparação fermentativa del-aminoácidos usando bactérias corineforme
CN110042107B (zh) 红花CtACO1基因、其编码蛋白质及应用
WO2002072768A3 (en) ISOGENIC ss-CATENIN CELL LINES, AND METHODS OF MAKING AND USING SAME
Rauè et al. Occurrence in Bacillus licheniformis of Two Species of 5‐S RNA with Multiple Differences in Primary Structure
CN118360300A (zh) 一种表达尿酸氧化酶的环状rna、制备方法及应用
JPH0998779A (ja) トレハロース合成酵素、その製法及びそれを用いたトレハロースの製造法
Brachet From chemical to molecular sea urchin embryology
CN104726466A (zh) 牛樟芝Biotin蛋白基因及其克隆和测序方法
CN117343919A (zh) 一种类黄酮双羟基位点糖基转移酶及其应用
CN113862272A (zh) 沉默中华绒螯蟹Dsx基因的dsRNA以及其应用
CN110283841A (zh) 一种作物铁锌生物强化方法

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8305328-0

Effective date: 19850917

Format of ref document f/p: F